Cano Health (CANO – Research Report) received a Hold rating and a price target from Citi analyst Jason Cassorla today. The company’s shares closed yesterday at $1.52.
Cassorla covers the Healthcare sector, focusing on stocks such as Community Health, Tenet Healthcare, and Cano Health. According to TipRanks, Cassorla has an average return of -4.3% and a 48.84% success rate on recommended stocks.
Cano Health has an analyst consensus of Hold, with a price target consensus of $2.21.
See Insiders’ Hot Stocks on TipRanks >>
Based on Cano Health’s latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $866.91 million and a GAAP net loss of $60.59 million. In comparison, last year the company earned a revenue of $704.34 million and had a net profit of $660 thousand
Based on the recent corporate insider activity of 39 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of CANO in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Jaws Acquisition Corp is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities.
Read More on CANO:
- Cano Health Announces Financial Results for the Second Quarter 2023
- Cano Health options imply 20.0% move in share price post-earnings
- Investor group with 35% stake in Cano ‘condemn Board’s egregious conduct’
- Cano Health holders Cooperstone, Gold, Sternlicht address leadership transition
- Cano Health Gains on Top Rung Shakeup
